Sorrento Announces Publication of Data in Cell Press Journal Med Describing Discovery and Preclinical...
Careers
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - October 13, 2022,Arrowhead...
Oncotelic Announces Pet2DAO Website is Live,Oncotelic Announces Pet2DAO Website is Live - read this...
Teknova Announces Early Access Program for Novel Products to Address Critical Pain Points in...
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D.,...
Genomic Testing Cooperative and its Co-Op Members First to Use Artificial Intelligence to Distinguish...
Remix Therapeutics Appoints Robert Gagnon as Chief Financial Officer,Remix Therapeutics Appoints Robert Gagnon as...
EpiBiologics Launches with $50 million Series A Financing to Advance Next-Generation Protein Degradation Platform,EpiBiologics...
Raven-Symone Pearman-Maday to host inaugural Halloween for Hope organized by new City of Hope...
RG6501 (OpRegen®) Phase 1/2a Clinical Results to Be Presented at 2023 Retinal Cell and...
Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent...
Convergent Therapeutics to Announce Clinical Trial Updates on its Lead Candidate at the American...
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of...
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized...
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022,Seer to Report...
Xalud Therapeutics Presents Clinical Data on XT-150 in Knee Osteoarthritis at the 2023 Osteoarthritis...
Allergy Partners Announces Collaboration with Aimmune Therapeutics to Provide PALFORZIA® [Peanut (Arachis hypogaea) Allergen...
Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound GelKane’s first FDA...
QT Imaging, the University of Illinois, and the Sunnybrook Research Institute Receive $3.1 Million...
American Aires Inc. Provides Corporation Update, American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF)...
Congruence Therapeutics Announces Presentations at the 2023 European and North America CCG UGM &...
Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory documents,Annual Meeting of...
Favorable Five-Year Survivorship of Implantable Shock Absorber and Reduction of Arthroplasty Risk in High-Risk...
Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial,Cybin Initiates First-in-Human Dosing...
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and...
Altimmune Obesity Drug Well-Positioned Despite Safety Data,Mayank Mamtani, managing director and group head of...
Microbiome Insights Launches Cutting-Edge Metatranscriptomic Sequencing Services,Microbiome Insights Launches Cutting-Edge Metatranscriptomic Sequencing Services -...
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing...
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance...
MoonLake Immunotherapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides a Business...
